A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

Clinical trial NCT04116710 · COMPLETED

Trial details

NCT number: NCT04116710
Sponsor: Heat Biologics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2019-10-18
Primary completion: 2021-08-12
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.